Trial Profile
A phase II observational study of IB-1000 for Niemann-Pick-disease-type-C
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Acetylleucine (Primary)
- Indications Niemann-Pick disease type C
- Focus Therapeutic Use
- 26 Nov 2018 New trial record